Common non-oncologic medications, including antibiotics, antidiabetics, and NSAIDs, are associated with significant cardiovascular adverse effects ranging from arrhythmias to structural cardiomyopathy.
What are the cardiovascular adverse effects and underlying mechanisms of common non-oncologic medications?
This narrative review highlights the significant cardiovascular adverse effects associated with common non-oncologic medications, emphasizing the importance of clinical awareness in everyday practice.
Abstract Cardiovascular adverse effects of drugs has significant practical implications for patient management. While cardiovascular adverse effects have commonly been associated with oncologic therapeutics, a growing body of evidence suggests that non-oncologic medications can also be associated with significant cardiovascular harm. These adverse effects range from arrhythmias, conduction abnormalities, QT prolongation, heart failure, myocardial infarction, or structural cardiomyopathy. Non-oncologic drugs that have been implicated include antibiotics (e.g., macrolides, fluoroquinolones), antidiabetics (e.g., thiazolidinediones), non-steroidal anti-inflammatory drugs (NSAIDs), drugs for gastrointestinal and urological conditions, and most importantly, cardiovascular drugs. In this narrative review, we focus on the most common non-oncologic drugs that cause cardiovascular adverse effects, their proposed underlying mechanisms with particular emphasis on their clinical manifestations and clinical implications for everyday cardiovascular practice.
Bahit et al. (Fri,) conducted a review in Cardiovascular adverse effects of non-oncologic medications. Non-oncologic medications (e.g., antibiotics, antidiabetics, NSAIDs) was evaluated. Common non-oncologic medications, including antibiotics, antidiabetics, and NSAIDs, are associated with significant cardiovascular adverse effects ranging from arrhythmias to structural cardiomyopathy.